Glimepiride is an orally available medium-to-long acting sulfonylurea antidiabetic drug. Glimepiride is indicated to treat type 2 diabetes mellitus; its mode of action is to increase insulin production by the pancreas. Its use is contraindicated in patients with hypersensitivity to glimepiride or other sulfonylureas.
It lowers blood sugar by stimulating the release of insulin by pancreatic beta cells and by inducing increased activity of intracellular insulin receptors.
CAS no: 93479-97-1